Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
J Diabetes Sci Technol. 2024 May;18(3):562-569. doi: 10.1177/19322968241241005. Epub 2024 Apr 2.
We evaluated the feasibility of real-time continuous glucose monitoring (CGM) for titrating continuous intravenous insulin infusion (CII) to manage hyperglycemia in postoperative individuals in the cardiovascular intensive care unit and assessed their accuracy, nursing acceptance, and postoperative individual satisfaction.
Dexcom G6 CGM devices were applied to 59 postsurgical patients with hyperglycemia receiving CII. A hybrid approach combining CGM with periodic point-of-care blood glucose (POC-BG) tests with two phases (initial-ongoing) of validation was used to determine CGM accuracy. Mean and median absolute relative differences and Clarke Error Grid were plotted to evaluate the CGM accuracy. Surveys of nurses and patients on the use of CGMs experience were conducted and results were analyzed.
In this cohort (mean age 64, 32% female, 32% with diabetes) with 864 paired POC-BG and CGM values analyzed, mean and median absolute relative difference between POC-BG and CGM values were 13.2% and 9.8%, respectively. 99.7% of paired CGM and POC-BG were in Zones A and B of the Clarke Error Grid. Responses from nurses reported CGMs being very or quite convenient (n = 28; 93%) and it was favored over POC-BG testing (n = 28; 93%). Majority of patients (n = 42; 93%) reported their care process using CGM as being good or very good.
This pilot study demonstrates the feasibility, accuracy, and nursing convenience of adopting CGM via a hybrid approach for insulin titration in postoperative settings. These findings provide robust rationale for larger confirmatory studies to evaluate the benefit of CGM in postoperative care to improve workflow, enhance health outcomes, and cost-effectiveness.
我们评估了实时连续血糖监测(CGM)在心血管重症监护病房(CICU)中调整连续静脉胰岛素输注(CII)以管理术后高血糖患者的可行性,并评估了其准确性、护理接受程度和术后个体满意度。
将 Dexcom G6 CGM 设备应用于 59 例接受 CII 的术后高血糖患者。采用 CGM 与周期性即时床旁血糖(POC-BG)检测相结合的混合方法,分两个阶段(初始-持续)进行验证,以确定 CGM 的准确性。绘制平均和中位数绝对相对差异以及 Clarke 误差网格图来评估 CGM 的准确性。对护士和患者使用 CGM 的经验进行调查,并对结果进行分析。
在该队列(平均年龄 64 岁,32%为女性,32%患有糖尿病)中,分析了 864 对 POC-BG 和 CGM 值,POC-BG 和 CGM 值之间的平均和中位数绝对相对差异分别为 13.2%和 9.8%。99.7%的配对 CGM 和 POC-BG 值位于 Clarke 误差网格的 A 和 B 区。护士的回应报告 CGM 非常方便或相当方便(n=28;93%),并且优于 POC-BG 检测(n=28;93%)。大多数患者(n=42;93%)报告使用 CGM 的护理过程良好或非常好。
这项初步研究表明,采用混合方法通过 CGM 进行胰岛素滴定在术后环境中具有可行性、准确性和护理便利性。这些发现为更大规模的验证性研究提供了有力的依据,以评估 CGM 在术后护理中的益处,以改善工作流程、提高健康结果和成本效益。